| MeSH term | MeSH ID | Detail |
|---|---|---|
| Microvascular Angina | D017566 | 2 associated lipids |
| Carcinoma, Lobular | D018275 | 4 associated lipids |
| Chronic Disease | D002908 | 7 associated lipids |
| Leishmaniasis, Cutaneous | D016773 | 6 associated lipids |
| Carcinosarcoma | D002296 | 7 associated lipids |
| Arthritis, Reactive | D016918 | 3 associated lipids |
| Carcinoid Heart Disease | D002275 | 1 associated lipids |
| Hyperphosphatemia | D054559 | 1 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Ren H et al. | Effects of intermedin on proliferation, apoptosis and the expression of OPG/RANKL/M-CSF in the MC3T3-E1 osteoblast cell line. | 2015 | Mol Med Rep | pmid:26398911 |
| Yu SG et al. | Ursolic acid derivative ameliorates streptozotocin-induced diabestic bone deleterious effects in mice. | 2015 | Int J Clin Exp Pathol | pmid:26097549 |
| Schmitz F et al. | Repurposing an Osteoporosis Drug for β Cell Regeneration in Diabetic Patients. | 2015 | Cell Metab. | pmid:26094892 |
| Kondegowda NG et al. | Osteoprotegerin and Denosumab Stimulate Human Beta Cell Proliferation through Inhibition of the Receptor Activator of NF-κB Ligand Pathway. | 2015 | Cell Metab. | pmid:26094891 |
| Wu C et al. | Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin. | 2015 | Genes Dev. | pmid:25846796 |
| Åšwierkot J et al. | Assessment of the Effect of Methotrexate Therapy on Bone Metabolism in Patients with Rheumatoid Arthritis. | 2015 | Arch. Immunol. Ther. Exp. (Warsz.) | pmid:25837853 |
| Lin TH et al. | NF-κB decoy oligodeoxynucleotide enhanced osteogenesis in mesenchymal stem cells exposed to polyethylene particle. | 2015 | Tissue Eng Part A | pmid:25518013 |
| Kadlub N et al. | The calcineurin inhibitor tacrolimus as a new therapy in severe cherubism. | 2015 | J. Bone Miner. Res. | pmid:25491283 |
| Meijome TE et al. | GATA-1 deficiency rescues trabecular but not cortical bone in OPG deficient mice. | 2015 | J. Cell. Physiol. | pmid:25205203 |
| Solberg LB et al. | Tartrate-resistant acid phosphatase (TRAP) co-localizes with receptor activator of NF-KB ligand (RANKL) and osteoprotegerin (OPG) in lysosomal-associated membrane protein 1 (LAMP1)-positive vesicles in rat osteoblasts and osteocytes. | 2015 | Histochem. Cell Biol. | pmid:25201349 |